US equities
|
SPCX
$166.62
▲+4.82%
NVDA
$236.65
▲+1.15%
MU
$1,064.40
▼-0.98%
TSLA
$377.58
▲+1.89%
MSFT
$525.72
▲+1.58%
SNDK
$1,711.19
▼-0.51%
INTC
$117.18
▼-1.80%
META
$745.54
▲+2.40%
SPCX
$166.62
▲+4.82%
NVDA
$236.65
▲+1.15%
MU
$1,064.40
▼-0.98%
TSLA
$377.58
▲+1.89%
MSFT
$525.72
▲+1.58%
SNDK
$1,711.19
▼-0.51%
INTC
$117.18
▼-1.80%
META
$745.54
▲+2.40%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Enovis Corporation Common Stock
(NY:
ENOV
)
18.37
+0.60 (+3.38%)
Delayed Quote
Updated: 11:44 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enovis Corporation Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
3 Small-Cap Stocks We Approach with Caution
Today 0:35 EDT
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...
Via
StockStory
1 Oversold Stock Ready to Bounce Back and 2 That Underwhelm
September 28, 2026
Rock-bottom prices don’t always mean rock-bottom businesses. The stocks we’re examining today have all touched their 52-week lows, creating a classic investo...
Via
StockStory
2 Russell 2000 Stocks on Our Watchlist and 1 We Brush Off
September 21, 2026
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...
Via
StockStory
3 Reasons ENOV is Risky and 1 Stock to Buy Instead
September 17, 2026
Shareholders of Enovis would probably like to forget the past six months even happened. The stock dropped 20.4% and now trades at $18.67. This may have inves...
Via
StockStory
Topics
Artificial Intelligence
Insider at Medical Device Maker Buys More Than 7,500 Shares
↗
September 14, 2026
Engert's $150,000 purchase represents a 14% increase to his direct holdings, signaling confidence despite stock's -37% one-year decline.
Via
The Motley Fool
Topics
Regulatory Compliance
Q2 Earnings Highlights: Enovis (NYSE:ENOV) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
September 03, 2026
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including En...
Via
StockStory
Enovis Targets Robotic Surgery Expansion With €155M eCential Robotics Deal
↗
September 01, 2026
Enovis (NYSE:ENOV) said it has entered a binding offer to acquire eCential Robotics, a developer of surgical robotics technology, in a move the orthopedic company said will expand its...
Via
MarketBeat
Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics
September 01, 2026
From
Enovis Corporation
Via
GlobeNewswire
Enovis to Participate in the 2026 Wells Fargo Healthcare Conference
August 31, 2026
From
Enovis Corporation
Via
GlobeNewswire
3 Stocks Under $50 We Approach with Caution
August 26, 2026
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
Via
StockStory
Enovis Q2 Earnings Call Highlights
↗
August 08, 2026
Enovis (NYSE:ENOV) reported second-quarter 2026 sales of $583 million, up 3% on a reported basis and 5% organically, as growth in its Reconstruction business offset a slower but still expanding...
Via
MarketBeat
Topics
Earnings
Economy
Why Enovis (ENOV) Shares Are Sliding Today
August 06, 2026
What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) fell 12.8% in the afternoon session after the company reported second-quar...
Via
StockStory
Enovis (NYSE:ENOV) Posts Q2 CY2026 Sales In Line With Estimates
August 06, 2026
Medical technology company Enovis Corporation (NYSE:ENOV) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 3.2% year on year to $582.8 mill...
Via
StockStory
Enovis Announces Second Quarter 2026 Results
August 06, 2026
From
Enovis Corporation
Via
GlobeNewswire
Enovis (ENOV) Reports Q2: Everything You Need To Know Ahead Of Earnings
August 04, 2026
Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting earnings this Thursday morning. Here’s what to expect. Enovis beat analysts’ reve...
Via
StockStory
Topics
Artificial Intelligence
1 Unprofitable Stock to Own for Decades and 2 Facing Challenges
July 28, 2026
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...
Via
StockStory
3 of Wall Street’s Favorite Stocks We Approach with Caution
July 27, 2026
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
Via
StockStory
STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know
July 17, 2026
What Happened? A number of stocks fell in the afternoon session after a key industry player warned that changes to some insurance plans could slow U.S. proce...
Via
StockStory
Stocks making big moves this week: HCA Healthcare, UnitedHealth, CrowdStrike, RXO, and Enovis
July 17, 2026
Check out the companies making headlines this week: HCA Healthcare (NYSE:HCA): Hospital operator HCA Healthcare (NYSE:HCA) fell by 6.7% on Tuesday after the ...
Via
StockStory
Enovis to Host Second Quarter 2026 Results Conference Call on August 6th
July 17, 2026
From
Enovis Corporation
Via
GlobeNewswire
Enovis (ENOV) Stock Trades Up, Here Is Why
July 13, 2026
What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 3.6% in the afternoon session after the company announced the U.S. ...
Via
StockStory
Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care
July 13, 2026
From
Enovis Corporation
Via
GlobeNewswire
Why Enovis (ENOV) Stock Is Trading Up Today
July 06, 2026
What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 15% in the afternoon session after the Centers for Medicare & Medic...
Via
StockStory
4 Top Growth Stocks Worth Buying Under $100 Today
↗
July 03, 2026
These four under-the-radar stocks are built to benefit from powerful secular trends that could reward patient, long-term investors.
Via
The Motley Fool
1 Oversold Stock Primed to Rebound and 2 We Find Risky
June 24, 2026
The past year hasn’t been kind to the stocks featured in this article. Each has tumbled to its lowest point in 12 months, leaving investors to decide whether...
Via
StockStory
Topics
Bonds
Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1
June 10, 2026
Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Enovis (NYSE:ENOV)...
Via
StockStory
Enovis Launches Spinamic® Hybrid Scoliosis Brace, Combining Corrective Performance with Improved Wearability for Children and Teens
June 08, 2026
The DonJoy Spinamic® Hybrid Scoliosis Brace is a first-of-its-kind device that integrates rigid corrective elements into a breathable, adjustable design to improve both clinical outcomes and patient...
From
Enovis Corporation
Via
GlobeNewswire
3 Reasons ENOV is Risky and 1 Stock to Buy Instead
June 05, 2026
Over the last six months, Enovis’s shares have sunk to $22.66, producing a disappointing 16.1% loss - a stark contrast to the S&P 500’s 10% gain. This might ...
Via
StockStory
Topics
Artificial Intelligence
Stocks
3 Healthcare Stocks That Fall Short
May 28, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destocking...
Via
StockStory
ront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now?
↗
May 22, 2026
Enovis develops orthopedic and rehabilitation devices for healthcare providers, serving a broad spectrum of musculoskeletal patient needs.
Via
The Motley Fool
Topics
Regulatory Compliance
< Previous
1
2
3
4
5
6
7
8
9
Next >
